Literature DB >> 18034311

Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models.

M Paul Gleeson1, Andrew M Davis, Kamaldeep K Chohan, Stuart W Paine, Scott Boyer, Claire L Gavaghan, Catrin Hasselgren Arnby, Cecilia Kankkonen, Nan Albertson.   

Abstract

In-silico models were generated to predict the extent of inhibition of cytochrome P450 isoenzymes using a set of relatively interpretable descriptors in conjunction with partial least squares (PLS) and regression trees (RT). The former was chosen due to the conservative nature of the resultant models built and the latter to more effectively account for any non-linearity between dependent and independent variables. All models are statistically significant and agree with the known SAR and they could be used as a guide to P450 liability through a classification based on the continuous pIC50 prediction given by the model. A compound is classified as having either a high or low P450 liability if the predicted pIC(50) is at least one root mean square error (RMSE) from the high/low pIC(50) cut-off of 5. If predicted within an RMSE of the cut-off we cannot be confident a compound will be experimentally low or high so an indeterminate classification is given. Hybrid models using bulk descriptors and fragmental descriptors do significantly better in modeling CYP450 inhibition, than bulk property QSAR descriptors alone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18034311     DOI: 10.1007/s10822-007-9139-6

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  39 in total

Review 1.  Update information on human P450s.

Authors:  F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2002 Feb-May       Impact factor: 4.518

2.  A comparison of relative abundance, activity factor and inhibitory monoclonal antibody approaches in the characterization of human CYP enzymology.

Authors:  Matthew G Soars; Harry V Gelboin; Kristopher W Krausz; Robert J Riley
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

3.  Greater than the sum of its parts: combining models for useful ADMET prediction.

Authors:  Sean E O'Brien; Marcel J de Groot
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

4.  In silico human and rat Vss quantitative structure-activity relationship models.

Authors:  M Paul Gleeson; Nigel J Waters; Stuart W Paine; Andrew M Davis
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

Review 5.  Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.

Authors:  S Ekins; M J de Groot; J P Jones
Journal:  Drug Metab Dispos       Date:  2001-07       Impact factor: 3.922

6.  A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.

Authors:  S Rao; R Aoyama; M Schrag; W F Trager; A Rettie; J P Jones
Journal:  J Med Chem       Date:  2000-07-27       Impact factor: 7.446

7.  Crystal structure of human cytochrome P450 2D6.

Authors:  Paul Rowland; Frank E Blaney; Martin G Smyth; Jo J Jones; Vaughan R Leydon; Amanda K Oxbrow; Ceri J Lewis; Mike G Tennant; Sandeep Modi; Drake S Eggleston; Richard J Chenery; Angela M Bridges
Journal:  J Biol Chem       Date:  2005-12-13       Impact factor: 5.157

8.  Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli.

Authors:  D F McGinnity; S J Griffin; G C Moody; M Voice; S Hanlon; T Friedberg; R J Riley
Journal:  Drug Metab Dispos       Date:  1999-09       Impact factor: 3.922

Review 9.  The influence of DMPK as an integrated partner in modern drug discovery.

Authors:  Robert J Riley; Iain J Martin; Anne E Cooper
Journal:  Curr Drug Metab       Date:  2002-10       Impact factor: 3.731

10.  The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution.

Authors:  Jason K Yano; Michael R Wester; Guillaume A Schoch; Keith J Griffin; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2004-07-16       Impact factor: 5.157

View more
  9 in total

1.  On the interpretation and interpretability of quantitative structure-activity relationship models.

Authors:  Rajarshi Guha
Journal:  J Comput Aided Mol Des       Date:  2008-09-11       Impact factor: 3.686

2.  IDSite: An accurate approach to predict P450-mediated drug metabolism.

Authors:  Jianing Li; Severin T Schneebeli; Joseph Bylund; Ramy Farid; Richard A Friesner
Journal:  J Chem Theory Comput       Date:  2011-11-08       Impact factor: 6.006

3.  Trainable structure-activity relationship model for virtual screening of CYP3A4 inhibition.

Authors:  Remigijus Didziapetris; Justas Dapkunas; Andrius Sazonovas; Pranas Japertas
Journal:  J Comput Aided Mol Des       Date:  2010-09-01       Impact factor: 3.686

4.  Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen Scanning.

Authors:  Toshihiro Aoki; Ikumi Hyohdoh; Noriyuki Furuichi; Sawako Ozawa; Fumio Watanabe; Masayuki Matsushita; Masahiro Sakaitani; Kenji Morikami; Kenji Takanashi; Naoki Harada; Yasushi Tomii; Koji Shiraki; Kentaro Furumoto; Mitsuyasu Tabo; Kiyoshi Yoshinari; Kazutomo Ori; Yuko Aoki; Nobuo Shimma; Hitoshi Iikura
Journal:  ACS Med Chem Lett       Date:  2014-01-22       Impact factor: 4.345

Review 5.  Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools.

Authors:  Naiem T Issa; Henri Wathieu; Abiola Ojo; Stephen W Byers; Sivanesan Dakshanamurthy
Journal:  Curr Drug Metab       Date:  2017       Impact factor: 3.731

Review 6.  Computational methods and tools to predict cytochrome P450 metabolism for drug discovery.

Authors:  Jonathan D Tyzack; Johannes Kirchmair
Journal:  Chem Biol Drug Des       Date:  2019-01-15       Impact factor: 2.817

7.  Multiple CH/π Interactions Maintain the Binding of Aflatoxin B₁ in the Active Cavity of Human Cytochrome P450 1A2.

Authors:  Jun Wu; Sisi Zhu; Yunbo Wu; Tianqing Jiang; Lingling Wang; Jun Jiang; Jikai Wen; Yiqun Deng
Journal:  Toxins (Basel)       Date:  2019-03-12       Impact factor: 4.546

Review 8.  Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.

Authors:  Jayalakshmi Sridhar; Jiawang Liu; Maryam Foroozesh; Cheryl L Klein Stevens
Journal:  Molecules       Date:  2012-08-03       Impact factor: 4.411

9.  Linear Interaction Energy Based Prediction of Cytochrome P450 1A2 Binding Affinities with Reliability Estimation.

Authors:  Luigi Capoferri; Marlies C A Verkade-Vreeker; Danny Buitenhuis; Jan N M Commandeur; Manuel Pastor; Nico P E Vermeulen; Daan P Geerke
Journal:  PLoS One       Date:  2015-11-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.